Habib J. Dable - 04 Nov 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role: Director
Signature: /s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol: RLAY
Transactions as of: 04 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Nov 2025, 16:33:51 UTC
Previous filing: 21 Jul 2025
Next filing: 07 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dable Habib J	Director	C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE	/s/ Soo-Yeun Lim, as Attorney-in-Fact	06 Nov 2025	0001690773

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RLAY	Stock Option (Right to Buy)	Award	$0	+207,931		$0.000000	207,931	04 Nov 2025	Common Stock	207,931	$6.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after November 4, 2025, subject to the reporting person's continued service with the Issuer through each vesting date.